Variation in these parameters might also explain why some studies suggest that the combination of metformin and 2-DG reduces viability of various cancer cell lines, independent of their p53 status44, 45 as well as why sensitivity of MDA-MB-231 cells to metformin differs between studies48, 49, 59. This evidence concerns the gene TP53 and cancer.